The Impact of Mavacamten on the Pathophysiology of Hypertrophic Cardiomyopathy: A Narrative Review.
Am J Cardiovasc Drugs. 2022 Apr 18. doi: 10.1007/s40256-022-00532-x. Online ahead of print.
Am J Cardiovasc Drugs. 2022.
PMID: 35435607
Review.